Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Int J Pharm Compd. 2015 Sep-Oct;19(5):357-65.
Topical corticosteroids are the cornerstone of treatment for the majority of psoriasis patients. However, potential side effects of topical corticosteroids (i.e., cutaneous atrophy, telangiectasias, hypothalamic-pituitary axis suppression), coupled with the complex pathophysiology of psoriasis and the individual needs/preferences of psoriasis patients, represent a few of the limitations associated with topical corticosteroid monotherapy. While the combination of some agents with varying mechanisms of action has proven to be an effective strategy for improving efficacy and reducing concomitant drug application, others have displayed less efficacy, harm, and/or reduced cost-effectiveness. The purpose of this article is to review novel topical therapeutic combinations for the management of psoriasis and explore the role compounding pharmacies can have in providing healthcare providers and patients with effective and affordable alternative psoriasis therapies.
外用皮质类固醇是大多数银屑病患者治疗的基石。然而,外用皮质类固醇的潜在副作用(即皮肤萎缩、毛细血管扩张、下丘脑-垂体轴抑制),再加上银屑病复杂的病理生理学以及银屑病患者的个体需求/偏好,这些都是外用皮质类固醇单一疗法存在的一些局限性。虽然一些作用机制不同的药物联合使用已被证明是提高疗效和减少联合用药的有效策略,但其他联合用药的疗效、安全性和/或成本效益较低。本文旨在综述用于治疗银屑病的新型外用治疗组合,并探讨复方药房在为医疗保健提供者和患者提供有效且经济实惠的银屑病替代疗法方面可以发挥的作用。